0,936  0,003  Antihypercholesterolemic
0,916  0,002  Cholesterol antagonist
0,911  0,004  Carcinogenic
0,903  0,004  Teratogen
0,896  0,004  Embryotoxic
0,877  0,003  NOS3 expression inhibitor
0,851  0,001  UGT1A4 substrate
0,838  0,011  Antiinflammatory
0,823  0,005  Respiratory analeptic
0,818  0,002  Hair growth stimulant
0,815  0,005  Chemopreventive
0,814  0,005  Bone diseases treatment
0,805  0,008  TNF expression inhibitor
0,806  0,009  CYP3A4 substrate
0,781  0,005  Antiosteoporotic
0,777  0,002  Pregnane X receptor agonist
0,775  0,002  Anticataract
0,789  0,018  Apoptosis agonist
0,772  0,003  Anesthetic
0,760  0,003  Anesthetic general
0,751  0,003  Prostatic (benign) hyperplasia treatment
0,745  0,005  Hepatic disorders treatment
0,739  0,001  5-Alpha-reductase 1 inhibitor
0,740  0,002  Antihyperlipoproteinemic
0,732  0,001  5-Alpha-reductase 2 inhibitor
0,732  0,007  Sensitization
0,716  0,003  UGT2B1 substrate
0,717  0,007  CYP2C19 substrate
0,701  0,004  Amyotrophic lateral sclerosis treatment
0,691  0,001  Cholesterol synthesis inhibitor
0,688  0,008  Analeptic
0,685  0,006  Lipoprotein disorders treatment
0,679  0,001  5-Alpha-reductase inhibitor
0,674  0,004  Sedative
0,669  0,005  Antipruritic, allergic
0,663  0,008  Proliferative diseases treatment
0,656  0,002  UGT2B4 substrate
0,652  0,005  UDP-glucuronosyltransferase substrate
0,632  0,003  Androgen antagonist
0,642  0,026  Transcription factor NF kappa B inhibitor
0,612  0,009  Antipsoriatic
0,598  0,004  Antiacne
0,591  0,002  UGT2B7 substrate
0,590  0,005  Diuretic
0,603  0,034  Antineoplastic (breast cancer)
0,585  0,017  Chemoprotective
0,571  0,004  Contraceptive
0,569  0,002  Prostate disorders treatment
0,579  0,013  Inflammatory Bowel disease treatment
0,580  0,015  CTGF expression inhibitor
0,580  0,016  Immunosuppressant
0,576  0,012  Apoptosis antagonist
0,565  0,002  Sodium/bile acid cotransporter inhibitor
0,564  0,002  Contraceptive female
0,569  0,015  Cytotoxic
0,572  0,019  Atherosclerosis treatment
0,556  0,003  Autism spectrum disorders treatment
0,555  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,548  0,014  NOS2 expression inhibitor
0,533  0,004  Interferon gamma antagonist
0,533  0,010  Hypolipemic
0,525  0,003  Antiinfertility, female
0,521  0,004  Growth factor agonist
0,540  0,025  Prostate cancer treatment
0,518  0,003  Lipocortins synthesis antagonist
0,528  0,019  Immunomodulator
0,508  0,004  Abortion inducer
0,519  0,019  Antifungal
0,545  0,046  Caspase 9 stimulant
0,534  0,041  Antidiabetic
0,534  0,041  Cyclophilin D inhibitor
0,532  0,040  Antineoplastic (lung cancer)
0,489  0,003  Antipruritic, non-allergic
0,492  0,007  Hepatoprotectant
0,504  0,021  Antiepileptic
0,493  0,022  AR expression inhibitor
0,499  0,029  Immunostimulant
0,486  0,020  Metabolic disease treatment
0,477  0,011  Interleukin 2 agonist
0,472  0,006  Sulfotransferase substrate
0,474  0,011  UGT1A1 substrate
0,462  0,004  DNA polymerase I inhibitor
0,469  0,013  Antineoplastic (liver cancer)
0,461  0,010  Muscle relaxant
0,450  0,004  UGT2B9 substrate
0,452  0,009  UGT1A3 substrate
0,451  0,020  Nitric oxide antagonist
0,447  0,024  ICAM1 expression inhibitor
0,450  0,028  Antineoplastic (pancreatic cancer)
0,461  0,045  CYP2C9 substrate
0,420  0,009  Male reproductive disfunction treatment
0,439  0,030  Antineoplastic (brain cancer)
0,411  0,005  Hedgehog signaling inhibitor
0,408  0,004  Farnesoid X receptor antagonist
0,408  0,006  Endometrios treatment
0,431  0,030  Antineoplastic (glioma)
0,431  0,031  Antihypertensive
0,434  0,037  Antineoplastic (ovarian cancer)
0,381  0,003  Androgen agonist
0,380  0,013  Carcinogenic, group 3
0,406  0,039  Antineoplastic (melanoma)
0,372  0,005  Liver cirrhosis treatment
0,391  0,026  UGT1A6 substrate
0,355  0,005  Contraceptive male
0,352  0,003  CDC25A inhibitor
0,357  0,017  Antiviral (Influenza)
0,342  0,003  Liver X receptor alpha agonist
0,410  0,072  Antibacterial
0,373  0,040  Antioxidant
0,346  0,014  Phospholipase C inhibitor
0,395  0,065  Antileukemic
0,351  0,024  Antiparkinsonian, rigidity relieving
0,346  0,021  Platelet adhesion inhibitor
0,337  0,012  Antiviral (Influenza A)
0,357  0,035  Antineoplastic (glioblastoma multiforme)
0,326  0,005  Retinoprotector
0,348  0,030  Interleukin agonist
0,348  0,036  Antineoplastic (renal cancer)
0,330  0,021  Antiviral (Herpes)
0,348  0,041  Antipyretic
0,311  0,005  Alcohol dehydrogenase substrate
0,312  0,009  Psychosexual dysfunction treatment
0,303  0,002  RNA-directed RNA polymerase stimulant
0,325  0,030  Wound healing agent
0,297  0,002  Arachidonic acid antagonist
0,294  0,005  Choleretic
0,290  0,005  Aromatase inhibitor
0,296  0,010  Antifungal enhancer
0,330  0,045  Renal disease treatment
0,289  0,014  Antidiabetic (type 1)
0,325  0,051  Antineoplastic (cervical cancer)
0,359  0,086  CYP2C19 inhibitor
0,294  0,024  Diabetic retinopathy treatment
0,288  0,019  UGT2B15 substrate
0,312  0,045  Angiogenesis stimulant
0,272  0,005  Estrogen agonist
0,274  0,008  UGT2B10 substrate
0,302  0,041  Antineoplastic (sarcoma)
0,266  0,005  Postmenopausal disorders treatment
0,269  0,014  LDLR expression enhancer
0,260  0,005  ABCA1 expression enhancer
0,332  0,087  Stroke treatment
0,249  0,004  Progesterone antagonist
0,268  0,024  Amylase inhibitor
0,294  0,052  Myocardial infarction treatment
0,300  0,061  UGT1A9 substrate
0,244  0,005  Actinic keratosis treatment
0,301  0,065  Antineoplastic (multiple myeloma)
0,263  0,027  Skeletal muscle relaxant
0,312  0,077  Antineoplastic (colorectal cancer)
0,290  0,056  Antidiabetic symptomatic
0,235  0,004  Bile acid receptor antagonist
0,286  0,055  Vascular (periferal) disease treatment
0,279  0,050  Gastrin inhibitor
0,232  0,003  Glycine receptor agonist
0,302  0,075  Antineoplastic (colon cancer)
0,299  0,077  Antineoplastic (endocrine cancer)
0,230  0,011  Menstruation disorders treatment
0,242  0,023  Toxic, respiratory center
0,276  0,058  Antineoplastic (lymphoma)
0,270  0,052  Antiulcerative
0,220  0,004  CDC25B inhibitor
0,231  0,016  Neurotrophic factor
0,241  0,027  Bone formation stimulant
0,250  0,041  P-glycoprotein inhibitor
0,234  0,031  Age-related macular degeneration treatment
0,249  0,047  VCAM1 expression inhibitor
0,231  0,032  Antipruritic
0,203  0,004  Liver X receptor agonist
0,200  0,004  Anabolic
0,238  0,045  Neurotrophic factor enhancer
0,216  0,025  Protein-tyrosine phosphatase 1B inhibitor
0,205  0,015  Growth stimulant
0,230  0,042  Eye irritation, high
0,199  0,013  Estrogen antagonist
0,257  0,073  Hypoglycemic
0,188  0,005  UGT2B11 substrate
0,217  0,035  Lipid peroxidase inhibitor
0,213  0,037  Protein kinase stimulant
0,176  0,005  Hypercalcemia treatment
0,204  0,034  Skin irritative effect
0,173  0,004  Aldosterone antagonist
0,230  0,066  Antihypertriglyceridemic
0,253  0,088  Antidiabetic (type 2)
0,205  0,045  Liver fibrosis treatment
0,239  0,079  Cardiovascular analeptic
0,200  0,041  Melanin inhibitor
0,224  0,065  Antialcoholic
0,174  0,020  Antineoplastic, alkylator
0,155  0,003  Vitamin D receptor antagonist
0,199  0,047  Protein-tyrosine phosphatase inhibitor
0,157  0,006  Glycine receptor antagonist
0,159  0,008  Premenstrual syndrome treatment
0,153  0,004  Liver X receptor beta agonist
0,154  0,005  Na+ K+ transporting ATPase inhibitor
0,174  0,027  Microtubule formation inhibitor
0,151  0,006  Anticholelithogenic
0,157  0,015  Inducible nitric-oxide synthase inhibitor
0,219  0,082  Cardiodepressant
0,185  0,048  NOS3 expression enhancer
0,168  0,034  Glutathione S-transferase substrate
0,141  0,009  Cushing's syndrome treatment
0,133  0,005  Mineralocorticoid receptor antagonist
0,143  0,017  Estrogen receptor beta antagonist
0,225  0,103  5 Hydroxytryptamine release stimulant
0,228  0,106  Radioprotector
0,124  0,003  Lipocortins synthesis agonist
0,149  0,028  Antineoplastic alkaloid
0,190  0,071  Mutagenic
0,148  0,031  Antineoplastic antibiotic
0,120  0,004  Glucocorticoid antagonist
0,134  0,019  Lanosterol 14 alpha demethylase inhibitor
0,123  0,009  Estrogen receptor beta agonist
0,131  0,024  Paget's disease treatment
0,120  0,015  Hyperparathyroidism treatment
0,162  0,059  Antidiarrheal
0,106  0,003  Cholesterol absorption inhibitor
0,109  0,008  Estrogen receptor alpha agonist
0,169  0,069  Muscular dystrophy treatment
0,222  0,127  Hypoxia-inducible factor 1 alpha inhibitor
0,099  0,005  Estrone sulfatase inhibitor
0,095  0,001  Hedgehog signaling activator
0,095  0,004  Progesterone agonist
0,180  0,093  Psychostimulant
0,088  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,106  0,024  Estrogen receptor alpha antagonist
0,142  0,060  Skin whitener
0,189  0,107  Antiprotozoal (Leishmania)
0,084  0,004  Parathyroid hormone antagonist
0,083  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,116  0,038  Posttraumatic stress disorder treatment
0,100  0,024  T cell inhibitor
0,207  0,136  CYP2D6 substrate
0,176  0,105  Antiparasitic
0,133  0,065  Antihemorrhagic
0,137  0,070  Antieczematic
0,129  0,062  Aldehyde dehydrogenase inhibitor
0,064  0,002  Vitamin D receptor agonist
0,066  0,006  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,066  0,007  Hypogonadism treatment
0,232  0,174  Antiobesity
0,117  0,059  SULT1A1 substrate
0,078  0,021  Acetyl-CoA transferase inhibitor
0,211  0,154  Caspase 3 stimulant
0,180  0,127  Tumour necrosis factor alpha release inhibitor
0,072  0,022  Heme oxygenase stimulant
0,181  0,133  DNA damaging
0,080  0,032  Female sexual dysfunction treatment
0,105  0,062  Toll-Like receptor 4 antagonist
0,067  0,024  Postcoital contraceptive
0,048  0,005  Glucocorticoid agonist
0,050  0,007  HMG CoA reductase inhibitor
0,086  0,045  Sleep apnea treatment
0,046  0,005  CYP24 inhibitor
0,044  0,004  Corticosteroid-like
0,053  0,013  Farnesoid X receptor agonist
0,087  0,048  Opioid kappa receptor antagonist
0,166  0,127  Antineoplastic enhancer
0,081  0,043  SULT1A2 substrate
0,110  0,074  Proteasome inhibitor
0,156  0,123  EphB2 antagonist
0,166  0,135  Antineoplastic (non-small cell lung cancer)
0,065  0,039  Nitric oxide donor
0,027  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,091  0,066  Prolactin inhibitor
0,051  0,026  Microtubule stabilization
0,063  0,040  HIV-1 integrase (Strand Transfer) inhibitor
0,027  0,006  Apical sodium codependent bile acid transporter inhibitor
0,140  0,120  Diabetic nephropathy treatment
0,031  0,012  1,3-Beta-glucan synthase inhibitor
0,172  0,155  Antituberculosic
0,053  0,037  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,157  0,143  Antiviral (HIV)
0,124  0,110  Phospholipase A2 inhibitor
0,083  0,070  Tocolytic
0,133  0,120  Interleukin 6 antagonist
0,152  0,143  Free radical scavenger
0,010  0,002  Transcortin receptor antagonist
0,085  0,077  Butyrylcholinesterase inhibitor
0,018  0,011  Ileal bile acid transport inhibitor
0,135  0,129  Antihelmintic
0,054  0,048  Botulinum neurotoxin type A inhibitor
0,006  0,002  Vitamin D-like
0,097  0,094  TRPA1 agonist
0,234  0,233  Alzheimer's disease treatment
0,028  0,028  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,053  0,052  Pregnane X receptor antagonist

